Two-dose therapy for S. aureus bloodstream infections on par with standard treatment NIH-supported trial finds dalbavancin safe, effective for treating bacteremia

https://www.nih.gov/news-events/news-releases/two-dose-therapy-s-aureus-bloodstream-infections-par-standard-treatment